Clinical Trial Update: Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the safety and efficacy of erenumab-aooe in Temporomandibular Disorder; the study is completed and results were posted on 2025-08-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Disorder

Drugs mentioned

• Erenumab-aooe (erenumab-aooe)

Snippet

Sponsor: Indiana University | Conditions: Temporomandibular Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-08-19